Company Filing History:
Years Active: 2020-2024
Title: Innovations of Luke Evnin in Oncolytic Viral Therapy
Introduction
Luke Evnin is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of oncolytic viral therapy, focusing on the delivery of therapeutic polypeptides. With a total of 3 patents, his work is paving the way for innovative cancer treatments.
Latest Patents
Evnin's latest patents include groundbreaking research on oncolytic viruses. One patent describes oncolytic viruses that comprise one or more nucleic acids encoding an engager molecule. These viruses can also include therapeutic molecules, providing a dual approach to cancer treatment. Another patent focuses on pseudotyped oncolytic viruses, which similarly encode an engager molecule and therapeutic molecules. Both patents detail pharmaceutical compositions containing these viruses and methods for treating cancer.
Career Highlights
Throughout his career, Luke Evnin has worked with notable companies such as Oncorus, Inc. and Virogin Biotech Canada Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas in the realm of cancer therapy.
Collaborations
Evnin has collaborated with esteemed colleagues, including Mitchell H. Finer and William Winston. These partnerships have further enhanced his research and development efforts in the field.
Conclusion
Luke Evnin's contributions to oncolytic viral therapy represent a significant advancement in cancer treatment. His innovative patents and collaborations highlight his commitment to improving therapeutic options for patients.